Exhaura presents data on EXH-001, an AAV9-hMMP-3 gene therapy for glaucoma treatment
Oct. 14, 2022
Glaucoma is an eye disease that damages the optic nerve, with the main cause being ocular hypertension due to high resistance to the outflow of aqueous humor.
